Replies to post #117624 on Anavex Life Sciences Corp (AVXL)

[powerwalker]

Folks, I don't believe Dr. M is looking to market 2-73 in the $1,000+ a month range. As we all point out, the research and development costs of 2-73 is nowhere near what the troglodytes have spent in their antiqued-thinking attempt to stop AD. Anavex's recovery of R&D is less than 1% of that groups' costs.

IMO, Dr. M will structure the pricing such that Anavex will receive between $600-900/year/patient on AD, probably less for other diseases/illnesses.

He has compassion, I believe, for those suffering and is not interested in gouging patients and their families.

[bas2020]

Do you honestly believe that BP will allow Anavex to maintain independence with these valuations? Most certainly NOT! If the anticipated results are confirmed (and we believe they will be), some BP will summon a hostile takeover if a friendly one cannot be negotiated.